Tyra Biosciences (TYRA) Financials

$22.03

$-1.51 (-6.41%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,710 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.27	0.55	0.52	0.35	0.30	0.14
Gross Profit	-0.27	-0.55	-0.52	-0.35	-0.30	-0.14
Operating Expenses	160.32	132.76	104.18	79.95	58.93	26.29
Operating Profit (EBIT)	-160.46	-132.76	-104.18	-79.95	-58.93	-26.29
Other Income	--	--	--	--	3.60	-0.01
Profit before Tax	-148.57	-119.95	-86.48	-69.13	-55.33	-26.29
Provision for Tax	--	--	--	--	-3.60	-0.15
Profit after Tax (Net Income)	-148.57	-119.95	-86.48	-69.13	-51.72	-26.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-55.33	-26.29

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	353.66	259.18	343.15	204.26	257.83	301.74
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.08	5.34	5.81	6.26	2.65	1.35
Current Liabilities	24.62	18.09	14.59	15.33	5.70	3.62
Total Liabilities	407.98	282.61	363.56	225.86	266.18	306.70

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	15.51	17.16	16.10	14.19	8.89	2.64
Current Assets	366.97	265.45	347.46	211.67	257.29	304.06
Total Assets	407.98	282.61	363.56	225.86	266.18	306.70
Total Debt*	5.58	5.81	6.22	6.50	2.62	1.18
Net Current Assets	342.35	247.36	332.87	196.34	251.59	300.44

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-95.14	-69.77	-50.14	-50.29	-23.75
Cash Flow from Investing Activities	--	72.46	-98.40	-144.61	-0.56	-0.65
Cash from Financing Activities	--	8.10	202.14	1.54	0.63	311.35
Net Cash Inflow / Outflow	--	--	--	--	-50.21	286.96

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.40	-2.01	-1.47	-1.61	-1.23	-0.63
Cash EPS ($)	--	-2.00	-1.46	-1.60	-1.22	-0.63
Adjusted Book Value ($)	--	4.35	5.83	4.75	6.11	7.31
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.60	-1.19	-1.17	-1.19	-0.57
Free Cash Flow per Share ($)	--	-1.60	-1.20	-1.18	-1.20	-0.59

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-39.05	-30.88	-29.34	-18.36	-18.06
ROE (%)	-48.48	-39.83	-31.60	-29.92	-18.49	-18.15
ROA (%)	-39.98	-37.13	-29.34	-28.10	-18.06	-16.20
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,435.95	435,683.33
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-40.38	-38.70	-25.09	-17.32	-124.16	-182.76
Net Profit Growth (%)	-40.38	-38.70	-25.09	-33.66	-97.86	-180.66
EPS Growth (%)	-33.92	-0.37	0.09	-0.31	-0.94	-0.53
Book Value Growth (%)	5.63	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-13.06	-9.46	-8.61	-6.20	-22.23
Price / Book Value	4.27	6.05	2.38	2.91	1.24	1.93
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.95	-11.03	-5.62	-5.79	-1.23	-10.71
Close Price ($)	31.94	26.29	13.90	13.85	7.60	14.07
High Price ($)	40.65	26.41	29.60	19.74	14.28	31.36
Low Price ($)	9.10	6.42	11.24	6.55	4.93	11.37
Market Cap ($ Cr)	1,709.74	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.02	0.03	0.01	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	14.91	14.67	23.81	13.80	45.13	84.09
Quick Ratio	14.91	--	--	--	--	--
Interest Coverage	--	--	--	--	-199.08	-187.77

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	591.36	1,848.07	3,004.26	1,076.01	1,647.54
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.